Viking Global Investors’s GeneDx Holdings WGS Stock Holding History

Viking Global Investors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37,161	Closed	-$5.47M	–	112
2021 Q4	$5.47M	Sell	37,161 -53,748	-59%	-$12M	0.02%	106
2021 Q3	$22.8M	Buy	+90,909	New	+$31.2M	0.06%	92
2021 Q2	–	Sell	-10,985	Closed	-$5.4M	–	112
2021 Q1	$5.4M	Buy	+10,985	New	+$5.71M	0.02%	93

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Viking Global Investors's WGS Position: Q1 2022 in Review

Viking Global Investors sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 37,161 shares — an estimated $5.47M sold.

Viking Global Investors first reported a position in WGS in Q1 2021 and held it in 3 quarters. The position peaked at $22.8M in Q3 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

Viking Global Investors reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
Viking Global Investors sold 37,161 GeneDx Holdings shares in Q1 2022, an estimated $5.47M.
Viking Global Investors first reported a position in GeneDx Holdings in Q1 2021 and held it in 3 quarters.
Viking Global Investors's GeneDx Holdings position peaked at $22.8M in Q3 2021.
108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.